These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33769068)

  • 1. Enriched pharmacokinetic behavior and antitumor efficacy of thymoquinone by liposomal delivery.
    Rachamalla HK; Bhattacharya S; Ahmad A; Sridharan K; Madamsetty VS; Mondal SK; Wang E; Dutta SK; Jan BL; Jinka S; Chandra Sekhar Jaggarapu MM; Yakati V; Mukhopadhyay D; Alkharfy KM; Banerjee R
    Nanomedicine (Lond); 2021 Apr; 16(8):641-656. PubMed ID: 33769068
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral bioavailability enhancement and hepatoprotective effects of thymoquinone by self-nanoemulsifying drug delivery system.
    Kalam MA; Raish M; Ahmed A; Alkharfy KM; Mohsin K; Alshamsan A; Al-Jenoobi FI; Al-Mohizea AM; Shakeel F
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():319-329. PubMed ID: 28482534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating anti-cancer activity of dual-loaded liposomes with thymoquinone and vitamin C.
    Munef A; Lafi Z; Shalan N
    Ther Deliv; 2024 Apr; 15(4):267-278. PubMed ID: 38449422
    [No Abstract]   [Full Text] [Related]  

  • 4. Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer.
    Odeh F; Ismail SI; Abu-Dahab R; Mahmoud IS; Al Bawab A
    Drug Deliv; 2012 Nov; 19(8):371-7. PubMed ID: 23043626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties,
    Shaarani S; Hamid SS; Mohd Kaus NH
    Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Stable Liposomal Drug Delivery System of Thymoquinone and Its In Vitro Anticancer Studies Using Breast Cancer and Cervical Cancer Cell Lines.
    Shariare MH; Khan MA; Al-Masum A; Khan JH; Uddin J; Kazi M
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of Liposomal Formulations for Ocular Delivery of Thymoquinone: In Vitro Evaluation in HCEC-2 e HConEC Cells.
    Landucci E; Bonomolo F; De Stefani C; Mazzantini C; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
    Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK
    Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoquinone-based nanotechnology for cancer therapy: promises and challenges.
    Ballout F; Habli Z; Rahal ON; Fatfat M; Gali-Muhtasib H
    Drug Discov Today; 2018 May; 23(5):1089-1098. PubMed ID: 29374534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel nanoparticle formulation of thymoquinone with a cold wet-milling system and its pharmacokinetic analysis.
    Nihei T; Suzuki H; Aoki A; Yuminoki K; Hashimoto N; Sato H; Seto Y; Onoue S
    Int J Pharm; 2016 Sep; 511(1):455-461. PubMed ID: 27451272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarriers: more than tour de force for thymoquinone.
    Rathore C; Rathbone MJ; Chellappan DK; Tambuwala MM; Pinto TJA; Dureja H; Hemrajani C; Gupta G; Dua K; Negi P
    Expert Opin Drug Deliv; 2020 Apr; 17(4):479-494. PubMed ID: 32077770
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) Formulation.
    Elmowafy M; Samy A; Raslan MA; Salama A; Said RA; Abdelaziz AE; El-Eraky W; El Awdan S; Viitala T
    AAPS PharmSciTech; 2016 Jun; 17(3):663-72. PubMed ID: 26304932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel.
    Odeh F; Naffa R; Azzam H; Mahmoud IS; Alshaer W; Al Bawab A; Ismail S
    Heliyon; 2019 Nov; 5(11):e02919. PubMed ID: 31844767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
    Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
    Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone Nanoparticles (TQ-NPs) in Kidney Toxicity Induced by Ehrlich Ascites Carcinoma (EAC): An In Vivo Study.
    Eltahir Z; Ibrahim M; Mohieldeen MY; Bayoumi A; Ahmed SM
    Can J Kidney Health Dis; 2024; 11():20543581241258812. PubMed ID: 38863503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine model.
    Khan MA; Aljarbou AN; Khan A; Younus H
    Int J Biol Macromol; 2015 May; 76():203-8. PubMed ID: 25709021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice.
    Ong YS; Saiful Yazan L; Ng WK; Noordin MM; Sapuan S; Foo JB; Tor YS
    Int J Nanomedicine; 2016; 11():5905-5915. PubMed ID: 27877037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and Characterization of Thymoquinone-Loaded Liposomes with Enhanced Topical Anti-inflammatory Activity.
    Mostafa M; Alaaeldin E; Aly UF; Sarhan HA
    AAPS PharmSciTech; 2018 Nov; 19(8):3490-3500. PubMed ID: 30218265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of thymoquinone on human pancreatic carcinoma orthotopically implanted in nude mice].
    Wang YM
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3111-4. PubMed ID: 22340651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy.
    Seguin J; Brullé L; Boyer R; Lu YM; Ramos Romano M; Touil YS; Scherman D; Bessodes M; Mignet N; Chabot GG
    Int J Pharm; 2013 Feb; 444(1-2):146-54. PubMed ID: 23380621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.